SCHEMBL30483774

SCHEMBL30483774

CCN(C)C(=O)C(=O)c1c[nH]c2cc(F)c(F)cc12

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 1/20 0.41
▸ PRKAB2 O43741 4/20 0.40
▸ PRKAG1 P54619 4/20 0.40
▸ PRKAA2 P54646 4/20 0.40
▸ PRKAA1 Q13131 4/20 0.40
▸ PRKAG3 Q9UGI9 4/20 0.40
▸ PRKAG2 Q9UGJ0 4/20 0.40
▸ PRKAB1 Q9Y478 4/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPK14 Q16539 2/20 0.38
▸ CYP2C19 P33261 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25423559 1.00 GPR84 (0.41) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL25748579 0.87 HTR1A (0.50) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31077764 0.85 MAPK14 (0.45) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL25748812 0.85 MAPK14 (0.45) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL24243751 0.84 KDM4E (0.50) ALDH1A1
SCHEMBL30053780 0.83 PRKAB2 (0.38) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL29206526 0.82 AR (0.36) ALDH1A1MAPK14CYP2C19CYP1A2
SCHEMBL25422112 0.81 PRKAB2 (0.39) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL31077697 0.81 PRKAB2 (0.39) GPR84PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL25423247 0.78 HTR1A (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME SAINT JOSEPH'S UNIVERSITY 2024-08-29 — — US disclosed
CN-117957211-A Fluorinated tryptamine compounds, analogs thereof, and methods of use thereof 圣约瑟夫大学 2024-04-30 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240286998-A1 FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME TPH2, TPH1, HNMT GPR84 528/4885PRKAB2 4224/4885PRKAG1 3982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback